UMN Pharma Inc. announced nonconsolidated earnings results for the six months ended June 30, 2017. For the six months, the company's net sales were JPY 2.943 million, operating loss was JPY 315.140 million, ordinary income was JPY 34.350 million, net income was JPY 34.032 million or JPY 2.79 per basic share. Net cash used in operating activities was JPY 330.107 million.

For the year ending December 31, 2017, on nonconsolidated basis, the company forecasts net sales to be JPY 153 million, operating loss to be JPY 512 million, ordinary loss to be JPY 167 million and net loss to be JPY 170 million or JPY 13.96 per share.